What Dicoon does

Dicoon is an independent medical diagnostic laboratory organization headquartered in Elst, Netherlands, that centralizes and delivers clinical chemistry, hematology, immunology, microbiology, parasitology, and clinical pharmacy testing for the Midden- and Zuid-Gelderland region. Founded on January 1, 2023, from the laboratory operations of three regional hospitals — Rijnstate (Arnhem), CWZ (Nijmegen), and Ziekenhuis Gelderse Vallei (Ede) — the company serves over 1,000 general practitioners and the founding hospitals through a network of blood draw stations (prikposten) and a unified MIPS/GLIMS10 laboratory information system now deployed across all sites.

Dicoon's service portfolio is built around three integrated laboratory disciplines: Medical Microbiology & Immunology (MMI), Clinical Chemistry, Hematology & Immunology (KCHI), and Clinical Pharmacy (KF). Specialty capabilities include a national SKML reference center for parasitology, in-house measles PCR, malaria molecular rapid testing, and an AI-based hemoglobinopathy prediction model recognized with the NVKC Wetenschaps- en Innovatieprijs 2024. Patient-facing services (blood collection, material submission, child-specific phlebotomy, and a digital locatiezoeker tool) are supported by a Kennisbank knowledge portal for healthcare providers and an internal Dicoon Academie training platform.

Revenue is generated primarily through laboratory diagnostic services billed directly to Dutch health insurers under the basic insurance package (basisverzekering), with a €385 deductible applying in 2025 and 2026. Dicoon maintains individual contracts with at least eight insurers (a.s.r., EU care, CZ, DSW, Menzis, ONVZ, Salland, VGZ, Zorg & Zekerheid), with Achmea/Zilveren Kruis in negotiation for 2026. The organization is currently expanding beyond its founding hospitals through a strategic collaboration with Sint Maartenskliniek (announced June 2026) and a Letter of Intent with Pantein Maasziekenhuis (December 2025), while divesting non-core anticoagulation services to TromboseZorg Dichtbij (effective March 2026).

Name

Dicoon

Legal name

Dicoon

Website

https://dicoon.nl

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Dicoon is an independent Dutch medical diagnostic laboratory founded in 2023 from three regional hospitals, centralizing clinical chemistry, microbiology, immunology, and pharmacy testing for over 1,000 GPs and hospitals across the Arnhem-Nijmegen-Ede region.

Ownership category

akta.pro rank

Product category

Medical Laboratory Diagnostics

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Central Laboratory Services (Core Lab Operations) (HLAGAEAA)

Keywords

• Medical laboratory diagnostics
• Clinical chemistry testing
• Microbiology immunology services
• Parasitology reference center
• Blood collection services

Headquarters

HQ city

Elst

HQ country

Netherlands

HQ region

Europe

Offices8 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Laboratory diagnostic services billed to health insurers: Dicoon bills laboratory tests directly to health insurers. Laboratory research and blood collection are covered under basic Dutch health insurance (basisverzekering), subject to the policyholder's deductible (eigen risico). Dicoon makes individual agreements with health insurers. The invoice consists of order costs (blood collection, materials, administrative processing) and laboratory research costs.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

Dicoon is a centralized medical diagnostic laboratory network serving Midden- and Zuid-Gelderland in the Netherlands, formed in 2023 from the consolidation of laboratory operations at three regional hospitals (Rijnstate, CWZ, and Ziekenhuis Gelderse Vallei). The organization provides clinical chemistry, hematology, immunology, medical microbiology, parasitology, and clinical pharmacy testing, along with a regional network of blood draw stations (prikposten) for sample collection. All sites operate on a unified GLIMS10 laboratory information system to deliver standardized diagnostic results to general practitioners, hospital specialists, and midwives across the Arnhem, Nijmegen, and Ede regions.

Product overview

Dicoon is a consolidated medical diagnostic laboratory network serving Mid- and South-Gelderland, formed in January 2023 from the merger of laboratory services from Rijnstate, CWZ, and Ziekenhuis Gelderse Vallei. The organisation provides a unified diagnostics offering built around three core laboratory disciplines — Medische Microbiologie & Immunologie (MMI), Klinische Chemie, Hematologie & Immunologie (KCHI), and Klinische Farmacie (KF) — supported by an extensive network of blood collection points (prikposten) across the Arnhem, Nijmegen, and Ede regions, with the main laboratory headquarters in Elst. Dicoon's service portfolio spans direct patient services (blood sampling, material submission, child-specific blood collection), specialist diagnostic testing (clinical chemistry, haematology, immunology, microbiology, parasitology, molecular diagnostics including PCR panels, pharmacogenetics, and drug screening), a digital location finder (locatiezoeker), an internal education platform (Dicoon Academie), a clinical knowledge portal for healthcare providers (Kennisbank), and a published fee schedule. All sites are progressively migrating to the unified GLIMS10 laboratory information system, enabling standardised ordering and result reporting across the network. The thrombosis service was transferred to TromboseZorg Dichtbij in March 2026, with Dicoon continuing blood collection for those patients.

Differentiator

Problem solved

Functional benefit

Products and services

• Bloedprikken (Blood Sampling Service) Blood collection at fixed and pop-up blood draw stations (prikposten) across the Arnhem, Nijmegen, and Ede regions, serving patients referred by GPs, specialists, and midwives. Some locations accept walk-ins, others require appointments booked online or by phone.
• Bloedprikken bij kinderen (Pediatric Blood Collection) Specialized blood collection service for children using age-adapted techniques (heel prick for infants, finger prick for older babies, arm/hand for older children) with preparation guidance for parents.
• Materiaal inleveren (Material Submission Service) Collection service for body materials such as urine, stool, smears, and sputum submitted for laboratory analysis. Patients deliver self-collected materials to Dicoon blood draw stations or via postal delivery using provided collection sets, with courier/bodedienst logistics operating 24/7.
• Medische Microbiologie & Immunologie (MMI) Laboratory Comprehensive medical microbiology and immunology laboratory performing clinical microbiology tests, parasitology, serology, molecular diagnostics (PCR for respiratory pathogens, measles, HPV, malaria), and immunology diagnostics. Headquartered in Elst since June 2024.
• Klinische Chemie, Hematologie & Immunologie (KCHI) Laboratory Clinical chemistry, haematology, and immunology laboratory providing tests including clinical chemistry panels, haematology, immunology, and anaemia analysis. Operating across CWZ Nijmegen, Rijnstate, and Ziekenhuis Gelderse Vallei, with progressive migration to GLIMS10.
• Klinische Farmacie (Clinical Pharmacy) Clinical pharmacy laboratory providing drug level monitoring, pharmacogenetics testing, and drug screening services for clinical decision support.
• Parasitology Reference Laboratory National reference laboratory for parasitology with SKML reference function covering both fecal and blood parasites. Active in national SKML networks, conducting scientific research, and providing education to GPs via Diagnostische Toets Overleggen (DTO), with Bert Mulder and Guido Bastiaens as primary specialists.
• Anemie-analyse (Anemia Analysis) Automated stepwise anaemia diagnosis panel: initial haemoglobin measurement triggers automatic follow-up diagnostics based on MCV value per a decision tree, with clinical chemist review for conclusions and additional tests.
• Fecesdiagnostiek (Stool Diagnostics) Stool analysis services including calprotectin (for IBD diagnosis), iFOBT (occult blood), faecal parasites, and elastase. Sample collection sets and dual-collection protocols apply depending on test combination.
• Mazelen PCR (Measles PCR Test) In-house PCR test for measles virus detection, performed Monday through Saturday with an average 3-day turnaround. Accepts throat swabs, nasopharynx swabs, saliva, and urine as sample materials.

Quantifiable outcome

• Patient satisfaction score of 9.0/10 for blood collection services (based on ~1800 respondents, end 2025)
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Eleven partnerships are on record, tiered core and minor.

• De Sint MaartenskliniekcoreStrategic or Co-development Partner · 22 June 2026Announced on 22 June 2026 that De Sint Maartenskliniek and Dicoon will continue together (samen verder), indicating an expanded or formalized collaboration beyond the initial founding hospitals.
• TromboseZorg Dichtbij (TZD)minorStrategic or Co-development Partner · 21 March 2026As of 21 March 2026, Dicoon's thrombosedienst (anticoagulation service) in the Ede region transfers to TromboseZorg Dichtbij. TZD focuses entirely on thrombosis care. Dicoon continues to perform diagnostics (blood draws) for TZD at the same blood draw stations. Patients see the same faces and use the same locations.
• Pantein MaasziekenhuiscoreStrategic or Co-development Partner · 17 December 2025Pantein Maasziekenhuis and Dicoon signed a Letter of Intent (intentieverklaring) to explore strategic cooperation in Clinical Chemistry and Clinical Pharmacy. Both organizations share a vision on regional collaboration in healthcare networks. The cooperation aims to bundle quality, increase chain efficiency, and create room for progress. Themes include: collaboration of specialist groups in the regions, education and training, digitalization and data exchange.
• MIPS / GLIMScoreTechnology or Integration · 29 November 2025GLIMS10 is Dicoon's Laboratory Information System (LIS) deployed across all Dicoon locations. Go-live at CWZ/Nijmegen in November 2024-2025 enables standardized diagnostic reporting and data exchange across the organization's distributed laboratory network.
• Stichting Global Health Initiative (GHI)coreStrategic or Co-development Partner · 15 March 2024Non-profit foundation bridging knowledge and technology in the Netherlands with healthcare needs in Uganda. Dicoon's arts-microbioloog Guido Bastiaens serves as GHI chairman. GHI connects TU Eindhoven researchers with Oeganda hospitals for malaria diagnostics. Received €70,000 research subsidy from TU/e Universiteitsfonds for a malaria bioluminescence-based technique study in Uganda. Also received €50,000 NWO Take-off Phase 1 subsidy for LUNAS technology market research in Uganda.
• Roche Diagnostics NederlandminorStrategic or Co-development PartnerDicoon participated in a diagnostics symposium organized by UMC Groningen, Certe, and Roche Diagnostics Nederland, discussing the future of laboratories in the Netherlands and regional collaboration models. CEO Harjan van Dam spoke on Dicoon's role in integrated diagnostics.
• Technische Universiteit Eindhoven (TU/e)coreStrategic or Co-development PartnerTU Eindhoven collaborated with Dicoon/Rijnstate on validating innovative molecular rapid tests for SARS-CoV-2 and malaria. Professor Maarten Merkx involved, along with PhD candidate Harm van der Veer. TU/e also involved in Global Health Initiative malaria projects including the NWO-subsidized LUNAS technology market research.
• Makerere University (Kampala, Uganda)minorStrategic or Co-development PartnerAcademic partner in Uganda collaborating with Dicoon, Rijnstate, and Stichting Global Health Initiative on malaria diagnostics research. Contributes to validation of molecular rapid tests and LUNAS technology evaluation in malaria-endemic settings.
• CerteminorStrategic or Co-development PartnerCerte co-organized a symposium with UMC Groningen and Roche Diagnostics on the future of laboratories in the Netherlands, where Dicoon shared its experience with regional diagnostic collaboration and integrated diagnostics.
• Hogeschool Leiden - Centrum Bioscience en Diagnostiek (CBD)minorStrategic or Co-development PartnerDicoon partnered with CBD to develop an in-company training program for clinical chemistry analysts. Training uses Team-Based Learning (TBL) approach combining knowledge transfer with team culture strengthening. Resulted in several participants becoming trainers themselves. Addresses shortage of clinical chemistry analysts and supports continuous professional development.
• Kumi Hospital (Uganda)minorStrategic or Co-development PartnerRural hospital in a malaria-endemic area involved as testing site for bioluminescence-based malaria diagnostic techniques developed through the Global Health Initiative collaboration with TU Eindhoven and Dicoon.

Scale indicators7 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• Certe: Dutch regional medical diagnostic laboratory serving Northern Netherlands (Groningen, Friesland, Drenthe) with a similar model of consolidated hospital laboratory services, GP referral network, and blood draw stations. Direct structural comparable as another regional Dutch lab cooperative.
• Atalmedial: Amsterdam-region diagnostic center formed from a hospital laboratory merger, providing clinical chemistry, microbiology, and immunology to regional hospitals and GPs. Direct peer with a comparable multi-hospital consolidation model.
• Star-shl: Rotterdam-based diagnostic center providing clinical chemistry, microbiology, and pathology services to hospitals, GPs, and patients in the South Holland region. Direct peer as another Dutch regional lab serving hospitals and primary care with comparable service mix.
• Reinier Haga Medisch Diagnostisch Centrum: Combined diagnostic center of the Reinier Haga hospital group in The Hague region, providing integrated clinical chemistry, microbiology, and pathology services. Direct peer operating a similar hospital-affiliated centralized lab model.

Regional players

• Result Laboratorium (Albert Schweitzer Ziekenhuis): Dordrecht-region diagnostic center associated with the Albert Schweitzer Hospital, providing routine and specialized clinical chemistry and hematology services. Regional peer with similar hospital-anchored diagnostic operating model.
• Stichting Diagnostiek Friesland (De Friese Wouden): Frisian regional diagnostic center providing laboratory services to hospitals and primary care in Friesland province. Regional peer operating a similar model of consolidated diagnostics with hospital partnerships and prikposten network.
• Jeroen Bosch Lab (PAMM): Regional medical microbiological laboratory serving the Jeroen Bosch Hospital and surrounding GPs in the 's-Hertogenbosch region. Regional peer with comparable hospital-based microbiology and immunology service profile.

Broad incumbents

• Eurofins Clinical Diagnostics Netherlands: Dutch arm of Eurofins Scientific offering clinical diagnostic testing, including microbiology, molecular diagnostics, and specialty assays, with a strong international commercial footprint. Broader incumbent competitor for both routine and specialized testing.
• SYNLAB Netherlands: National and pan-European commercial medical diagnostics operator with broad routine and specialty test menu serving Dutch hospitals, GPs, and occupational health. National-scale competitor putting pricing and contracting pressure on regional players like Dicoon.

Others

• Roche Diagnostics Nederland: Major in-vitro diagnostics manufacturer and supplier of analyzers, reagents, and clinical chemistry/immunoassay platforms used by Dutch labs including Dicoon. Ecosystem participant and co-organizer of the laboratory-future symposium where Dicoon's CEO presented; relevant for procurement dynamics and innovation partnership potential.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/dicoon
• Facebookfacebook.com/Dicoon-100090916418807

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dicoon